Journal of Yeungnam Medical Science

Yeungnam University College of Medicine, Yeungnam University Institute Medical Science (영남대 의대 학술지 편집위원회)
권호 표지
DOI QR코드

DOI QR Code

Solar retinopathy related to antidepressant use in a patient with major depressive disorder: a case report

  • Eun-Jin Cheon (Department of Psychiatry, Yeungnam University College of Medicine)
  • Received : 2024.02.23
  • Accepted : 2024.04.11
  • Published : 2024.07.31
Download PDF
⟨ Previous Next ⟩

Abstract

This case report is a unique case of solar retinopathy following antidepressant-induced mydriasis and highlights the need for comprehensive ophthalmic evaluation in patients treated with medications having mydriatic effects. A 49-year-old female patient who had received long-term antidepressant therapy presented with bilateral visual impairment after prolonged sun exposure. Fundoscopy confirmed solar retinopathy, which was attributed to drug-induced mydriasis. Medication adjustments and sun protection strategies led to full visual recovery, underscoring the importance of interdisciplinary awareness. This case emphasizes the challenges associated with the simultaneous management of psychiatric and ophthalmic conditions and highlights the need for routine ophthalmic evaluation of patients prescribed antidepressants with reported ocular side effects.

Keywords

Acknowledgement

The author would like to express sincere gratitude to Dr. Jung Ho Lee, an ophthalmologist, for providing invaluable ophthalmic consultations during the preparation of this manuscript.

References

  1. Richa S, Yazbek JC. Ocular adverse effects of common psychotropic agents: a review. CNS Drugs 2010;24:501-26.  https://doi.org/10.2165/11533180-000000000-00000
  2. Devadason DS, Mahmood S, Stanga PE, Bishop PN. Solar retinopathy in a patient with bipolar affective disorder. Br J Ophthalmol 2006;90:247. 
  3. Anaclerio AM, Wicker HS. Self-induced solar retinopathy by patients in a psychiatric hospital. Am J Ophthalmol 1970;69:731-6.  https://doi.org/10.1016/0002-9394(70)93412-4
  4. Schatz H, Mendelblatt F. Solar retinopathy from sun-gazing under the influence of LSD. Br J Ophthalmol 1973;57:270-3.  https://doi.org/10.1136/bjo.57.4.270
  5. Bechmann M, Ehrt O, Thiel MJ, Kristin N, Ulbig MW, Kampik A. Optical coherence tomography findings in early solar retinopathy. Br J Ophthalmol 2000;84:547-8.  https://doi.org/10.1136/bjo.84.5.546b
  6. Davies S, Elliott MH, Floor E, Truscott TG, Zareba M, Sarna T, et al. Photocytotoxicity of lipofuscin in human retinal pigment epithelial cells. Free Radic Biol Med 2001;31:256-65.  https://doi.org/10.1016/S0891-5849(01)00582-2
  7. Jain A, Desai RU, Charalel RA, Quiram P, Yannuzzi L, Sarraf D. Solar retinopathy: comparison of optical coherence tomography (OCT) and fluorescein angiography (FA). Retina 2009;29:1340-5.  https://doi.org/10.1097/IAE.0b013e3181b0da88
  8. Tso MO, La Piana FG. The human fovea after sungazing. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1975;79:OP788-95. 
  9. Hope-Ross MW, Mahon GJ, Gardiner TA, Archer DB. Ultrastructural findings in solar retinopathy. Eye (Lond) 1993;7(Pt 1):29-33.  https://doi.org/10.1038/eye.1993.7
  10. Saletu B, Grunberger J. Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects. J Clin Psychiatry 1988;49(Suppl):59-71. 
  11. Deijen JB, Loriaux SM, Orlebeke JF, de Vries J. Effects of paroxetine and maprotiline on mood, perceptual-motor skills and eye movements in healthy volunteers. J Psychopharmacol 1989; 3:149-55.  https://doi.org/10.1177/026988118900300305
  12. Ramaekers JG, Muntjewerff ND, O'Hanlon JF. A comparative study of acute and subchronic effects of dothiepin, fluoxetine and placebo on psychomotor and actual driving performance. Br J Clin Pharmacol 1995;39:397-404.  https://doi.org/10.1111/j.1365-2125.1995.tb04468.x
  13. Schmitt JA, Riedel WJ, Vuurman EF, Kruizinga M, Ramaekers JG. Modulation of the critical flicker fusion effects of serotonin reuptake inhibitors by concomitant pupillary changes. Psychopharmacology (Berl) 2002;160:381-6.  https://doi.org/10.1007/s00213-001-0993-y
  14. Malone DA Jr, Camara EG, Krug JH Jr. Ophthalmologic effects of psychotropic medications. Psychosomatics 1992;33:271-7.  https://doi.org/10.1016/S0033-3182(92)71965-3
  15. Narurkar V, Smoller BR, Hu CH, Bauer EA. Desipramine-induced blue-gray photosensitive pigmentation. Arch Dermatol 1993;129:474-6.  https://doi.org/10.1001/archderm.1993.01680250086012
  16. Ming ME, Bhawan J, Stefanato CM, McCalmont TH, Cohen LM. Imipramine-induced hyperpigmentation: four cases and a review of the literature. J Am Acad Dermatol 1999;40(2 Pt 1):159-66.  https://doi.org/10.1016/S0190-9622(99)70182-9
  17. Taniguchi S, Hamada T. Photosensitivity and thrombocytopenia due to amitriptyline. Am J Hematol 1996;53:49-50.  https://doi.org/10.1002/1096-8652(199609)53:1<49::AID-AJH2830530102>3.0.CO;2-T
  18. Ljunggren B, Bojs G. A case of photosensitivity and contact allergy to systemic tricyclic drugs, with unusual features. Contact Dermatitis 1991;24:259-65.  https://doi.org/10.1111/j.1600-0536.1991.tb01719.x
  19. Constable PA, Al-Dasooqi D, Bruce R, Prem-Senthil M. A review of ocular complications associated with medications used for anxiety, depression, and stress. Clin Optom (Auckl) 2022;14:13-25.  https://doi.org/10.2147/OPTO.S355091
  20. Bouattour N, Bouattour W, Messedi N, Charfeddine F, Aribi L, Aloulou J. Mydriasis caused by ESCITALOPRAM: case report. Eur Psychiatry 2022;65(Suppl 1):S727-8.  https://doi.org/10.1192/j.eurpsy.2022.1878